AskVantage

Granata Bio

Granata Bio is a startup headquartered in Duxbury, United States, founded in 2020. It has raised at least $23.9m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.

Part of the 311 Institute Global Startups Directory. Last updated .

2020Founded
StartupStage
Duxbury, United StatesHeadquarters
BiotechnologyIndustry
$23.9m+Raised (SEC filings)
EarlyFunding stage
Biotechnology
See it on the interactive mapBook a Briefing

Funding

Granata Bio has raised at least $23.9m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.

R&D ecosystem

Granata Bio sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.

Related

Questions and answers

What does Granata Bio do?

Granata Bio is classed in biotechnology in its filings with the US Securities and Exchange Commission.

How much has Granata Bio raised?

At least $23.9m, according to its Form D filings with the US Securities and Exchange Commission.

Where is Granata Bio based?

Granata Bio is headquartered in Duxbury, United States.

When was Granata Bio founded?

Granata Bio was founded in 2020.

Source record: SEC EDGAR (Form D filings).

© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.